Type
ArticleAuthors
Amann, Rudolf I.Baichoo, Shakuntala
Blencowe, Benjamin J.
Bork, Peer
Borodovsky, Mark
Brooksbank, Cath
Chain, Patrick S. G.
Colwell, Rita R.
Daffonchio, Daniele G.
Danchin, Antoine
de Lorenzo, Victor
Dorrestein, Pieter C.
Finn, Robert D.
Fraser, Claire M.
Gilbert, Jack A.
Hallam, Steven J.
Hugenholtz, Philip
Ioannidis, John P. A.
Jansson, Janet K.
Kim, Jihyun F.
Klenk, Hans-Peter
Klotz, Martin G.
Knight, Rob
Konstantinidis, Konstantinos T.
Kyrpides, Nikos C.
Mason, Christopher E.
McHardy, Alice C.
Meyer, Folker
Ouzounis, Christos A.
Patrinos, Aristides A. N.
Podar, Mircea
Pollard, Katherine S.
Ravel, Jacques
Munoz, Alejandro Reyes
Roberts, Richard J.
Rossello-Mora, Ramon
Sansone, Susanna-Assunta
Schloss, Patrick D.
Schriml, Lynn M.
Setubal, Jogo C.
Sorek, Rotem
Stevens, Rick L.
Tiedje, James M.
Turjanski, Adrian
Tyson, Gene W.
Ussery, David W.
Weinstock, George M.
White, Owen
Whitman, William B.
Xenarios, Ioannis
KAUST Department
KAUSTDate
2019Permanent link to this record
http://hdl.handle.net/10754/670086
Metadata
Show full item recordAbstract
Despite some notable progress in data sharing policies and practices, restrictions are still often placed on the open and unconditional use of various genomic data after they have received official approval for release to the public domain or to public databases. These restrictions, which often conflict with the terms and conditions of the funding bodies who supported the release of those data for the benefit of the scientific community and society, are perpetuated by the lack of clear guiding rules for data usage. Existing guidelines for data released to the public domain recognize but fail to resolve tensions between the importance of free and unconditional use of these data and the “right” of the data producers to the first publication. This self-contradiction has resulted in a loophole that allows different interpretations and a continuous debate between data producers and data users on the use of public data. We argue that the publicly available data should be treated as open data, a shared resource with unrestricted use for analysis, interpretation, and publication.Citation
Amann, R. I., Baichoo, S., Blencowe, B. J., Bork, P., Borodovsky, M., Brooksbank, C., … Xenarios, I. (2019). Toward unrestricted use of public genomic data. Science, 363(6425), 350–352. doi:10.1126/science.aaw1280Sponsors
The viewsexpressed in thispaperarethoseof theauthors and do not reflect theiraffiliated centers or anysponsoring federalagencies.M.B.is supported byNIHR01GM128145. P.H. isco-founder,board member,and equityholder of Microba. K.T.K. is supported byNSF1759831.F.M.is supported byNIH 1R01AI123037-01 and NSF1645609.C.A.O.is supported by Elixir-GR (MIS#5002780)which is funded bytheOperational Programme NSRF2014-2020andcofinancedbyGreece and the European Union.A.A.N.Pis an advisor to LunaDNALLC, Synthetic Genomics and a consultant atOakRidge National Lab.K.S.P.isa consultant forTenaya Therapeutics,Phylagen, and uBiome.Journal
SCIENCEAdditional Links
https://www.sciencemag.org/lookup/doi/10.1126/science.aaw1280https://repository.helmholtz-hzi.de/bitstream/10033/622187/1/Amann%20et%20al.pdf
ae974a485f413a2113503eed53cd6c53
10.1126/science.aaw1280